Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
Authors
Keywords
-
Journal
Nature Communications
Volume 4, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-10-01
DOI
10.1038/ncomms3516
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Coevolution of Solid Stress and Interstitial Fluid Pressure in Tumors During Progression: Implications for Vascular Collapse
- (2013) Triantafyllos Stylianopoulos et al. CANCER RESEARCH
- Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
- (2013) Rakesh K. Jain JOURNAL OF CLINICAL ONCOLOGY
- Angiotensin II Type 1A Receptor Signaling Facilitates Tumor Metastasis Formation through P-Selectin–Mediated Interaction of Tumor Cells with Platelets and Endothelial Cells
- (2012) Hideki Amano et al. AMERICAN JOURNAL OF PATHOLOGY
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
- (2012) Paolo P. Provenzano et al. CANCER CELL
- Thrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanisms
- (2012) Mariya T. Sweetwyne et al. MATRIX BIOLOGY
- Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
- (2012) Vikash P. Chauhan et al. Nature Nanotechnology
- Losartan Slows Pancreatic Tumor Progression and Extends Survival of SPARC-Null Mice by Abrogating Aberrant TGFβ Activation
- (2012) Shanna A. Arnold et al. PLoS One
- Angiotensin II Facilitates Breast Cancer Cell Migration and Metastasis
- (2012) Sylvie Rodrigues-Ferreira et al. PLoS One
- Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors
- (2012) T. Stylianopoulos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TGF- blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma
- (2012) J. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fluorescent Nanorods and Nanospheres for Real-Time In Vivo Probing of Nanoparticle Shape-Dependent Tumor Penetration
- (2011) Vikash P. Chauhan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Reduced Risk of Breast Cancer Recurrence in Patients Using ACE Inhibitors, ARBs, and/or Statins
- (2011) Young Kwang Chae et al. CANCER INVESTIGATION
- Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
- (2011) A. G. Sorensen et al. CANCER RESEARCH
- Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination
- (2011) Daniel Keizman et al. EUROPEAN JOURNAL OF CANCER
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
- (2011) B. Diop-Frimpong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impaired lymphatic contraction associated with immunosuppression
- (2011) S. Liao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Scaling rules for diffusive drug delivery in tumor and normal tissues
- (2011) James W. Baish et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK Antagonism
- (2011) J. P. Habashi et al. SCIENCE
- Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies
- (2011) Vikash P. Chauhan et al. Annual Review of Chemical and Biomolecular Engineering
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
- (2011) David G. DeNardo et al. Cancer Discovery
- Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice
- (2010) Chiyo Doi et al. BMC CANCER
- Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine
- (2010) Y Nakai et al. BRITISH JOURNAL OF CANCER
- Angiotensin-(1-7) Reduces Fibrosis in Orthotopic Breast Tumors
- (2010) K. L. Cook et al. CANCER RESEARCH
- Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks
- (2010) Walid S Kamoun et al. NATURE METHODS
- Angiotensin II Induces Connective Tissue Growth Factor and Collagen I Expression via Transforming Growth Factor–β–Dependent and –Independent Smad Pathways
- (2009) Fuye Yang et al. HYPERTENSION
- Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
- (2009) Stefan Wilop et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging
- (2009) Benjamin J Vakoc et al. NATURE MEDICINE
- AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist
- (2009) D. R. Rhodes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis
- (2008) Barbara Ulmasov et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Targeting the TGFβ, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma
- (2008) Andrew Leask CELLULAR SIGNALLING
- Perfusion CT: Noninvasive Surrogate Marker for Stratification of Pancreatic Cancer Response to Concurrent Chemo- and Radiation Therapy
- (2008) Mi-Suk Park et al. RADIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started